Trials / Not Yet Recruiting
Not Yet RecruitingNCT07229391
Behavior Therapy vs Education for Persistent Headache After Mild TBI
Examining a Novel Treatment for Persistent Headache After Mild Traumatic Brain Injury
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- VA Office of Research and Development · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will test a new treatment, called Headache reprocessing, for persistent post-traumatic headache. The new treatment will be compared to a headache education intervention. The main objectives of the study are to examine the feasibility, safety, and clinical appropriateness of the new treatment.
Detailed description
Persistent post-traumatic headache (PPTH) is a common, debilitating health condition affecting Veterans and civilians. Relative to other headache disorders, PPTH is especially severe and impairing. PPTH has no established first-line treatments at this time. This research seeks to develop a new behavioral treatment, called headache reprocessing, to target fear and avoidance behaviors and cognitions, and associated neural changes, that drive PPTH. This trial will test the feasibility, safety, and clinical appropriateness of Headache Reprocessing Therapy by comparing it to a headache education control condition in a randomized controlled trial. We will randomize 60 Veterans with PPTH to take part in this study. Headache reprocessing and the educational control intervention will be delivered in group format over eight sessions (one per week for eight weeks). This intervention has the potential to improve available treatment options for PPTH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Headache reprocessing | Behavior therapy focused on sensations and avoidance behaviors |
| BEHAVIORAL | Headache education | Education about ways to limit and manage headaches |
Timeline
- Start date
- 2027-10-01
- Primary completion
- 2030-01-01
- Completion
- 2030-04-01
- First posted
- 2025-11-17
- Last updated
- 2025-12-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07229391. Inclusion in this directory is not an endorsement.